Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Children's Oncology Drug Alliance formed to develop neuroblastoma treatment

May 7, 2014

Ono and Nissan Chemical discontinue license agreement

May 2, 2014

Parion Sciences regains rights to ENaC inhibitors

May 2, 2014

ReGenX and AAVLife sign license agreement in Friedreich's ataxia

April 30, 2014

Ambrx and Zhejiang Hisun form cancer collaboration

April 30, 2014

Agenus to identify anticancer antibodies for Merck & Co

April 29, 2014

Medivation and OncoFusion to research compounds targeting BET proteins

April 29, 2014

Daiichi Sankyo licenses Agendia biomarker technology for cancer drug development

April 28, 2014

Teva and Takeda sign agreement for rasagiline in Japan

April 28, 2014

Celgene acquires late-stage product for Crohn's disease

April 28, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...